I am an Assistant Professor at The University of Hong Kong (HKU) Business School. My research investigates how organizations can be more resilient when facing disruptions in their environment, with a particular focus on the healthcare industry. Before joining HKU, I was a postdoctoral researcher at Columbia Business School, working with Carri Chan. I earned a PhD from Questrom School of Business, Boston University, advised by Anita Carson.
[06/28/25] Our paper, ML-guided Cancer Screening, was awarded an honorable mention at the 2025 MSOM Practice-Based Research Competition!
[05/15/25] I am humbled to be a recipient of the 2024 M&SOM Meritorious Service Award!
[05/10/25] Our paper ML-guided Cancer Screening won the CHOM Best Paper Competition!
[04/10/25] SIG presentation! ML-guided Cancer Screening is selected for presentation at the Healthcare SIG, 2025 MSOM Conference.
[04/06/25] Our paper ML-guided Cancer Screening has been selected as a finalist for the CHOM Best Paper Competition.
Machine Learning-Guided Cancer Screening: The Benefits of Proactive Care. with Carri Chan, Keith Boell, Elliot Mitchell, Abdul Tariq, and David Vawdrey. Major revision at Manufacturing & Service Operations Management.
First, Do No Harm: Do Staffing Shortages Drive Abuse and Malfeasance in US Nursing Homes? with Jong Myeong Lim, and Ken Moon. Major revision at Manufacturing & Service Operations Management.
Time to Recover Market Share: A New Metric of Supply Chain Resilience. with Anita Carson and Rena Conti.
The Impact of Senior Living Facilities on Medicare Spending. with Ann Bartel, Carri Chan, Patrick Wu, and Fanyin Zheng. Under review.
Stockpiling at the Onset of the COVID-19 Pandemic: An Empirical Analysis of National Prescription Drug Sales and Prices. with Anita Carson, Erin Fox, and Rena Conti. Management Science, 2024.
Linking Medication Errors to Drug Shortages: Evidence from Heparin Supply Chain Disruption Caused by Hurricane Maria. with Anita Carson and Rena Conti. Manufacturing & Service Operations Management, 2025.